glp-1 receptor agonists should be avoided in patients with GI Adverse Effects of Glucagon-Like Peptide-1 GLP-1 Receptor Agonists: Mascots &

Mazdutide overall appears to achieve superior weight loss, in shorter periods of times compared to GLP1R agonists

[DOI] [PubMed] [Google Scholar] 7.Mller T.D., Blher M., Tschp M.H., DiMarchi R.D

A prespecified analysis of pooled data from the STEP-HFpEF and STEP-HFpEF DM trials demonstrated that significantly more patients treated with Wegovy 2.4 mg SC once weekly had an improvement of at least one in New York Heart Association (NYHA) functional class compared to those who received placebo (32.6% versus 21.5%, respectively

Not as a fitness goal

Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Brnighausen T, Vollmer S

doi: 10.1136/bmj.k872